Thomas J. Schnitzer

Response relationship of VAS and Likert scales in osteoarthritis efficacy measurement

James A. Bolognese, Thomas J. Schnitzer, Elliot Ehrich · Osteoarthritis and Cartilage · 2003 · 137 citations

Chronic Musculoskeletal Condition, Response Relationship, Osteoarthritis +4

The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis

Thomas J. Schnitzer, K. E. Truitt, Roy Fleischmann et al. · Clinical Therapeutics · 1999 · 137 citations

Drug Safety, Rheumatology, Rheumatoid Disorder +9

Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: A randomized, double-blind, placebo-controlled study

Thomas J. Schnitzer, Marc Kamin, William H. Olson · Arthritis & Rheumatism · 1999 · 99 citations · Full text

CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial

Yan Jin, Claire Smith, David Monteith et al. · Osteoarthritis and Cartilage · 2018 · 53 citations · Full text

Cgrp Blockade, Rheumatology, Randomized Clinical Trial +10

Subregional femorotibial cartilage morphology in women – comparison between healthy controls and participants with different grades of radiographic knee osteoarthritis

M.-P. Hellio Le Graverand, R. Buck, Bradley T. Wyman et al. · Osteoarthritis and Cartilage · 2009 · 50 citations · Full text

Rheumatology, Musculoskeletal Imaging, Cartilage Degeneration +12